As of September 09, 2026, the three largest insider holders of UNCY are Gaurav Aggarwal (Director, 1.79Mn shares), Gaurav Aggarwal (Director, 347.02K shares), Shalabh K. Gupta (Ceo, 252.74K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Gaurav Aggarwal | Director | 0 | 1,789,915 | 1,789,915 | 86.6% | 26 Aug, 2025 |
| 2 | Shalabh K. Gupta | Ceo | 252,745 | 0 | 252,745 | 12.2% | 13 Jul, 2023 |
| 3 | Douglas Jermasek | Evp Of Corporate Strategy | 17,501 | 0 | 17,501 | 0.8% | 13 Jul, 2023 |
| 4 | Pramod Gupta | Evp, Pharmaceuticals And Bd | 4,185 | 0 | 4,185 | 0.2% | 13 Jul, 2023 |
| 5 | Brigitte Schiller | Director | 2,674 | 0 | 2,674 | 0.1% | 30 Aug, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 14 May, 2026 | Sandeep Laumas | Director | Acquired A | 47,941 | $0.00 | $0 | 47,941 | Direct |
| 14 May, 2026 | Sara Kenkare-Mitra | Director | Acquired A | 47,941 | $0.00 | $0 | 47,941 | Direct |
| 14 May, 2026 | Sara Kenkare-Mitra | Director | Acquired A | 84,200 | $0.00 | $0 | 84,200 | Direct |
| 14 May, 2026 | John Townsend | Cfo | Acquired A | 169,500 | $0.00 | $0 | 169,500 | Direct |
| 14 May, 2026 | Douglas Jermasek | Evp, Corporate Strategy | Acquired A | 169,500 | $0.00 | $0 | 169,500 | Direct |
| 14 May, 2026 | Shalabh K. Gupta | Ceo | Acquired A | 762,200 | $0.00 | $0 | 762,200 | Direct |
| 14 May, 2026 | Sandeep Laumas | Director | Acquired A | 84,200 | $0.00 | $0 | 84,200 | Direct |
| 14 May, 2026 | Pramod Gupta | Evp, Pharmaceuticals And Bd | Acquired A | 169,500 | $0.00 | $0 | 169,500 | Direct |
| 14 May, 2026 | Sandeep Laumas | Director | Acquired A | 42,100 | $0.00 | $0 | 126,300 | Direct |
| 14 May, 2026 | Sara Kenkare-Mitra | Director | Acquired A | 42,100 | $0.00 | $0 | 126,300 | Direct |
| 14 May, 2026 | Sara Kenkare-Mitra | Director | Acquired A | 84,200 | $0.00 | $0 | 84,200 | Direct |
| 14 May, 2026 | Shalabh K. Gupta | Ceo | Acquired A | 762,200 | $0.00 | $0 | 762,200 | Direct |
| 14 May, 2026 | Sara Kenkare-Mitra | Director | Acquired A | 42,100 | $0.00 | $0 | 126,300 | Direct |
| 14 May, 2026 | Pramod Gupta | Evp, Pharmaceuticals And Bd | Acquired A | 169,500 | $0.00 | $0 | 169,500 | Direct |
| 14 May, 2026 | John Townsend | Cfo | Acquired A | 169,500 | $0.00 | $0 | 169,500 | Direct |
| 14 May, 2026 | Douglas Jermasek | Evp, Corporate Strategy | Acquired A | 169,500 | $0.00 | $0 | 169,500 | Direct |
| 14 May, 2026 | Sandeep Laumas | Director | Acquired A | 84,200 | $0.00 | $0 | 84,200 | Direct |
| 14 May, 2026 | Sandeep Laumas | Director | Acquired A | 42,100 | $0.00 | $0 | 126,300 | Direct |
| 25 Aug, 2025 | Gaurav Aggarwal | Director | Acquired C | 652,900 | — | — | 1,789,915 | Indirect |
| 25 Aug, 2025 | Gaurav Aggarwal | Director | Disposed D | 3,199 | $1,000.00 | $3.20Mn | 0 | Indirect |